Fujifilm India launches the next phase of ‘NEVER STOP SCREENING TO REDUCE DIAGNOSTIC DELAYS’ Campaign to promote early diagnosis of TB in Kerala
TB is a curable disease, and the campaign aims to spread this message The campaign will also focus on providing doorstep TB screening services to facilitate diagnosis Fujifilm India Pvt Ltd, a pioneer in
- TB is a curable disease, and the campaign aims to spread this message
- The campaign will also focus on providing doorstep TB screening services to facilitate diagnosis
Fujifilm India Pvt Ltd, a pioneer in diagnostic imaging and information systems for healthcare facilities, has launched the second phase of its campaign on TB “NEVER STOP: SCREENING TO REDUCE DIAGNOSTIC DELAYS” in Waynad, Kerala. The second phase of this campaign aims to increase awareness of TB as a curable disease and promote screening and early diagnosis among tea sector workers, difficult to reach the population in rural and urban areas including the tribal population. Under the campaign, Fujifilm India will support three mobile handheld X-ray machines and implementation of the project in community settings. Apart from symptomatic screening, Fujifilm would be providing nutrition support to identified TB patients in Waynad district.
Fujifilm aims to reach more than 5 million people and screen around 30,000 of them by using handheld X-ray machines. The project will also facilitate TB testing of identified presumptive cases. In association with International Union Against TB and Lung Disease (The Union), the project aims to demonstrate a model for promoting early diagnosis of TB by utilizing newer solutions in community settings. Through the campaign, Fujifilm will be offering door-to-door awareness on TB and provide mobile digital X-ray services along with Qure.ai’s computed aided radiology software application designed with deep-learning for the intervention.
Speaking about the success of the campaign, Mr. Koji Wada, Managing Director, Fujifilm India Pvt Ltd, said, “We at Fujifilm have always been dedicated to offering the best medical innovations and technologies to improve the quality of life around the globe. Following the success of the first phase of our NEVER STOP: SCREENING TO REDUCE DIAGNOSTIC DELAYS campaign, we are extremely happy to complement government program in selected districts by reaching the underserved sections of society. As a diamond member of Corporate TB Pledge initiative, we’re closely working with the National Program to make India a TB-free country and will continue to support this endeavour in the coming months. We are determined to Never Stop innovating and making the world a healthier place.”
Fujifilm is a diamond member of Corporate TB Pledge (CTP), which is being implemented by International Union Against TB and Lung Disease (The Union) as part of USAID supported iDEFEAT TB project. Corporate TB Pledge initiative was jointly launched in 2019 by Government of India and USAID to galvanize corporate support in the fight against TB. More than 230 corporate partners have joined the Corporate TB Pledge initiative.
In line with the Government’s call to achieve the SDG targets related to TB by 2025, five years ahead of global targets, Fujifilm India aims to raise awareness about tuberculosis as a curable disease among hard-to-reach groups and facilitate early diagnosis of TB ultimately improving people’s quality of life. While tuberculosis is a serious disease, it is completely curable if diagnosed in time and the treatment is completed.